Navigation Links
Enteris BioPharma and Nordic BioScience's KeyBioScience Enter Strategic Licensing Agreement to Develop Metabolic Peptides Using Enteris' Proprietary Oral Drug Delivery and Manufacturing Platform
Date:9/30/2013

BOONTON, N.J., Sept. 30, 2013 /PRNewswire/ -- Enteris BioPharma, Inc., an industry leader in innovative oral dosage formulations, and KeyBioScience, a wholly-owned subsidiary of Nordic Bioscience, today announced a strategic licensing agreement for Enteris' oral drug delivery and recombinant manufacturing technologies to advance the development of KeyBioScience's recently acquired family of proprietary metabolic peptides for various indications, including the treatment of Type 2 diabetes, obesity and other inflammatory conditions with high unmet medical and socioeconomic needs. 

The licensing agreement with KeyBioScience marks the first significant revenue-generating partnership for Enteris since its inception in April 2013, and is representative of the company's broader "Feasibility-to-Licensing" strategy involving Peptelligence™, its peptide and small molecule oral drug delivery platform.  For KeyBioScience, the licensing agreement signals its transition to a clinical stage company following its formation by Nordic Bioscience. 

Under the terms of the agreement, Enteris will license to KeyBioScience its oral drug delivery and recombinant manufacturing technologies, as well as become the exclusive provider of pre-clinical and clinical trial API and solid dosage form finished product and will receive both fee-for-service revenues and royalties based on net sales of the developed products. 

Brian Zietsman, President and CFO of Enteris BioPharma, commented, "I cannot overemphasize the significance of this licensing agreement for Enteris and the excitement we share with Nordic Bioscience and its wholly-owned subsidiary KeyBioScience, especially given the tremendous potential therapeutic benefit and multi-billion dollar commercial potential of the compounds under development.  Importantly, for Enteris, this l
'/>"/>

SOURCE Enteris BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Enteris BioPharma Initiates Business and Development Activities Targeting Oral Delivery of Peptides and Small Molecule Therapeutics
2. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
3. PDL BioPharma Announces Adjusted Conversion Rates for Its Convertible Notes
4. CeNeRx BioPharma Completes $4.85 Million Financing
5. PDL BioPharma Completes Regular Quarterly Dividend Payment
6. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
7. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
8. Keryx Biopharmaceuticals to Present at JP Morgans 30th Annual Healthcare Conference
9. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
10. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
11. Galien Foundation Announces 2012 Awards Program For Best Biopharmaceutical Products and Best Medical Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... (PRWEB) July 23, 2014 OncLive® ... Cancer Center has joined its Strategic Alliance Partnership ... Alliance Partnership program, UNC Lineberger will have the ... raise awareness of its cutting-edge research initiatives, community-directed ... UNC Lineberger will work with OncLive to educate ...
(Date:7/23/2014)... 23, 2014 Adult stem cells ... are biological, but not magical. However, many ... treat them as if they were magical. , ... studies that constitute “stem cell tourism,” are evaluating ... to developing new regenerative medicine therapies. In reality, ...
(Date:7/22/2014)... NJ (PR Web) July 21, 2014 (PRWEB) July ... Center for Biomaterials, at Rutgers University. , ... information and ideas across the full spectrum of ... on selected research and development topics that represent ... Activities have been programmed to:, ...
(Date:7/22/2014)... 22, 2014 Even within a phylum so full of ... among other arthropods for its cruelty -- at least to ... the fly is a most predatory sort of parasite. It ... a smear of larvae, and leaves its wicked brood to ... , None of this would be possible without the fly,s ...
Breaking Biology Technology:OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 2The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 4The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 5The 2014 NJ Symposium on Biomaterials Science Earns Society for Biomaterials Endorsement 2Fly-inspired sound detector 2Fly-inspired sound detector 3Fly-inspired sound detector 4
... Inc. (Nasdaq: IDIX ) announced today that management ... programs at the Canaccord Adams Hepatitis C Conference on Tuesday, ... Barclay New York Hotel in New York City.The live and ... of Events" in the Idenix Investor Center at ...
... Agent to Find Partner to Co-Develop Company,s Chinese ... VEGAS, April 3 ... "Company") is pleased to announce that it ... an international marketing organization headquartered in New Jersey ...
... ChromaDex Corporation, (OTC Bulletin Board: CDXC) a ... today announced financial results for the 2008 Fiscal ... with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ... stockholders of $0.07 per share for the twelve ...
Cached Biology Technology:Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier 2ChromaDex Announces 2008 Year End Financial Results 2ChromaDex Announces 2008 Year End Financial Results 3
(Date:7/23/2014)... International Journal of Fuzzy Systems ( IJFS ... Association (TFSA). The cooperation will allow the journal to ... research., The International Journal of Fuzzy Systems ... the theory, design and application of fuzzy systems, soft ... from hardware to software. Launched in 1999, the quarterly ...
(Date:7/23/2014)... principal bacteria that cause dental caries, has increased ... possibly coinciding with dietary change linked to the ... a study by researchers from the Universitat Autnoma ... Genmica para la Biodiversidad (National Laboratory of Genomics ... time, have sequenced genetic material from this bacterium ...
(Date:7/23/2014)... equipment, trained personnel, and detection dogs to safeguard ... A revolutionary new electronic chip with nano-sized chemical ... easier. , The groundbreaking nanotechnology-inspired sensor, devised by ... School of Chemistry and Center for Nanoscience and ... picks up the scent of explosives molecules better ...
Breaking Biology News(10 mins):Ancient genetic material from caries bacterium obtained for the first time 2Nano-sized chip "sniffs out" explosives far better than trained dogs 2
... identified a specific class of pharmaceutical drugs that could ... Death Syndrome (SIDS), because their mothers smoked during pregnancy. ... the fetus to nicotine results in the inability to ... in a higher incidence of SIDS. In the ...
... recent years, obesity has taken on epidemic proportions in ... death and rising health care costs. According to Centers ... quarter of all American adults and more than 15 ... While recent research advances and treatment methods ...
... collaboration research carried out by the teams of Jordi ... and ngel Raya, Centre for Regenerative Medicine of Barcelona ... and Technological Research (CIEMAT), has resulted in the generation ... a genetic disease known as Fanconi anemia. The process ...
Cached Biology News:Simple drug treatment may prevent nicotine-induced SIDS: Study 2Researchers engineer metabolic pathway in mice to prevent diet-induced obesity 2Researchers engineer metabolic pathway in mice to prevent diet-induced obesity 3Genetically corrected blood cells obtained from skin cells from Fanconi anemia patients 2